SEC ownership of NERVGEN PHARMA CORP.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001751912.

Comparable stake leader

PFG Investments, LLC

Disclosed value leader

PFG Investments, LLC

Comparable rows

0/45

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001751912
Issuer location
Vancouver, British Columbia, Canada

Ownership snapshot

Top shareholders of NERVGEN PHARMA CORP. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PFG Investments, LLC
Disclosed value leader
PFG Investments, LLC
Comparable rows
0/45
Latest evidence
31 Mar 2026
13F Highest disclosed value: $757,770 45 rows are not safely comparable across share classes. Showing 1-8 of 45 holder rows.

Quick read

PFG Investments, LLC has the largest disclosed position value at $757.8K.

0 of 45 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PFG Investments, LLC's linked filing trail.
Disclosed position value Top 5
PFG Investments, LLC $757.8K
BANK OF AMERICA CORP /DE/ $756.5K
MARSHALL WACE, LLP $755.4K
ROYAL BANK OF CANADA $648K
Integrated Wealth Concepts LLC $327.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-8 of 45 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PFG Investments, LLC
13F
Company
13F
class O/S missing
$757,770
201,000 shares
31 Mar 2026
BANK OF AMERICA CORP /DE/
13F
Company
13F
class O/S missing
$756,473
200,656 shares
31 Mar 2026
MARSHALL WACE, LLP
13F
Company
13F
class O/S missing
$755,355
200,359 shares
31 Mar 2026
ROYAL BANK OF CANADA
13F
Company
13F
class O/S missing
$648,000
171,961 shares
31 Mar 2026
Integrated Wealth Concepts LLC
13F
Company
13F
class O/S missing
$327,293
86,815 shares
31 Mar 2026
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
13F
Company
13F
class O/S missing
$292,922
77,698 shares
31 Mar 2026
BANK OF MONTREAL /CAN/
13F
Company
13F
class O/S missing
$237,133
62,900 shares
31 Mar 2026
CAPTRUST FINANCIAL ADVISORS
13F
Company
13F
class O/S missing
$235,124
62,367 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 06 Jul 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for NERVGEN PHARMA CORP.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .